311 related articles for article (PubMed ID: 11378162)
21. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.
Undie AS; Friedman E
J Neurochem; 1994 Jul; 63(1):222-30. PubMed ID: 7911510
[TBL] [Abstract][Full Text] [Related]
23. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
25. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
Glass M; Felder CC
J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
[TBL] [Abstract][Full Text] [Related]
26. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
27. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
Cadogan AK; Alexander SP; Boyd EA; Kendall DA
J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
[TBL] [Abstract][Full Text] [Related]
28. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
LaHoste GJ; Yu J; Marshall JF
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
[TBL] [Abstract][Full Text] [Related]
29. Altered dopamine receptor mediated signal transmission in the striatum of aged rats.
May T; Sugawa M
Brain Res; 1993 Feb; 604(1-2):106-11. PubMed ID: 8457839
[TBL] [Abstract][Full Text] [Related]
30. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
Okada F; Horikawa T; Tokumitsu Y; Nomura Y
Neurochem Int; 1994 Jan; 24(1):23-7. PubMed ID: 8130732
[TBL] [Abstract][Full Text] [Related]
31. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
33. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
34. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation.
Steinberg R; Souilhac J; Rodier D; Alonso R; Emonds-Alt X; Le Fur G; Soubrié P
Neuroscience; 1998 May; 84(2):511-8. PubMed ID: 9539221
[TBL] [Abstract][Full Text] [Related]
35. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
Keefe KA; Gerfen CR
Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
[TBL] [Abstract][Full Text] [Related]
36. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
37. Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons.
Van Vliet BJ; Van Rijswijk AL; Wardeh G; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1993 Mar; 245(1):23-9. PubMed ID: 8386668
[TBL] [Abstract][Full Text] [Related]
38. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors.
Hu XT; White FJ
Neurosci Lett; 1997 Mar; 224(1):61-5. PubMed ID: 9132692
[TBL] [Abstract][Full Text] [Related]
39. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
[TBL] [Abstract][Full Text] [Related]
40. Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons.
Durham RA; Johnson JD; Eaton MJ; Moore KE; Lookingland KJ
Eur J Pharmacol; 1998 Aug; 355(2-3):141-7. PubMed ID: 9760028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
